Insider buying last 90 days
No open-market insider purchases were filed for EG in the last 90 days.
From Form 4 filings, dated to when each was filed.
This week's news flow around Everest centers on multiple law firms, including Levi & Korsinsky, Kaplan Fox, Rosen Law Firm, and Bronstein Gewirtz & Grossman, reminding investors of a pending securities class action concerning alleged underwriting and remediation failures in the company's U.S. casualty book, covering purchases between February 8, 2024 and October 27, 2025, with a lead plaintiff deadline of December 28, 2026. Separately, Neo Insurance Solutions announced HarborSTM, a new short-term medical insurance product underwritten by Everest Reinsurance, building on a nearly five-year relationship between the two organizations. A director-linked filing also noted a sale of 5,000 EG shares at $412.41 each.
Everest closes at $412.75, up 0.4%, sitting above both its 50-day average of $383.21 and 200-day average of $356.26, with the shorter average above the longer one. The GekkoIndex reads 51.6, placing the stock in the Neutral zone, up from a five-day change of 11.4. Price sits 3% above Gekko Fair Value of $400.86, within a 5% band.
The next earnings date falls on 3 February 2027, 85 days out and beyond a typical 20-trading-day hold. No insider, Congress, or unusual options activity appears in the respective windows. Seasonality over the next 20 trading days has averaged 0% across 5 years, rising in 3 of them. Analyst coverage shows 11 firms, with 4 at buy and 7 at hold, and a consensus target of $428.38.
Written by AI from the Nov 9, 2026 close and checked automatically against the figures on this page.
Everest scores 2 supportive, 2 mixed and 1 headwind across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
2 supportive2 mixed1 headwind
Above 50 and 200-day
Close $427.19 is above the 50-day ($386.76) and 200-day ($358.21) averages, and the 50-day is above the 200-day.
See the chart50, Neutral
Reading 50 is in the Neutral zone.
See the GekkoIndex5.4% above
Price is 5.4% above Gekko Fair Value (more than 5% above).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 80 days
Next report Feb 3, 2027, 80 days away — outside a typical 20-trading-day hold.
See earnings+0.3% on average
From this point in the calendar, the next 20 trading days averaged +0.3% over 5 years, rising in 2 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Everest closed at $427.19 on Nov 13, 2026, +31.4% over the past year, inside a 52-week range of $304.55 to $431.19.
Use the left and right arrow keys to read daily values.
Put EG on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Everest provides reinsurance and insurance coverage to clients in the United States, Europe and other international markets. Its offerings span property and casualty reinsurance, treaty and facultative arrangements, and specialty coverage lines including mortgage, catastrophe, marine, aviation, engineering, professional liability, credit and surety, motor, agriculture and crop, and political violence protection. The company also writes commercial property and casualty insurance directly to policyholders.
The business is structured into two segments, Insurance and Reinsurance. Reinsurance products reach the market through reinsurance brokers as well as direct dealings with ceding companies, while insurance products are distributed through brokers, surplus lines channels, general agents, wholesale and retail brokers, and program administrators. The company previously operated under the name Everest Re Group, Ltd. before adopting its current name in July 2023.
Everest was founded in 1973 and is headquartered in Hamilton, Bermuda. Its shares are listed on the NYSE under the ticker EG.
Everest’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 50, in the Neutral zone, unchanged over five sessions.
Unchanged over five sessions.
Reading for Nov 13, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 31 | +2.9% | +6.4% | ||
| Accumulation | 213 | +1.0% | +3.0% | ||
| Neutral (current zone) | 434 | −0.4% | −1.4% | ||
| Distribution | 20 | −1.4% | −2.7% | ||
| Selling | 4 | Too few readings yet | |||
Average EG share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +0.9% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
Everest trades 5.4% above Gekko Fair Value of $405.41, so the shares are overvalued on Gekko’s estimate.
Gekko’s own estimate of what Everest shares are worth, recalculated every trading day.
$405.41
Gekko Fair Value, Nov 14, 2026
5.4% Overvalued
At the end of Aug 2026 the price was 5.2% below the estimate.
No open-market insider purchases were filed for Everest, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for EG in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in EG were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Everest has been buying back its own shares.
From company filings.
1of the funds Gekko tracks holds EG.
Everest reports on Feb 3, 2027 (80 days away), and beat the EPS estimate in 4 of its last 8 reports.
Feb 3, 2027
80 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Apr 29, 2026 | $16.08 est $13.96 | $4.07B est $4.17B | +2.8% |
| Feb 4, 2026 | $13.26 est $13.36 | $4.42B est $4.49B | −1.2% |
| Oct 27, 2025 | $7.54 est $14.52 | $4.25B est $4.45B | −12.6% |
| Jul 30, 2025 | $17.36 est $15.14 | $4.40B est $3.89B | +1.1% |
| Apr 30, 2025 | $6.45 est $7.59 | $4.26B est $4.21B | −6.1% |
| Feb 3, 2025 | −$13.96 est −$17.03 | $4.61B est $4.16B | −1.7% |
| Oct 30, 2024 | $11.80 est $11.85 | $4.29B est $4.33B | −5.6% |
| Jul 31, 2024 | $16.85 est $16.59 | $4.23B est $4.32B | −5.4% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Everest is $433.38, +1.4% from the last close, from 11 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 11 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Nov 5 | Mizuho Securities | $453 | +6.0% |
| Nov 4 | KBW | $450 | +5.3% |
| Nov 2 | Citi | $445 | +4.2% |
| Nov 2 | UBS | $423 | −1.0% |
| Nov 2 | Cantor Fitzgerald | $419 | −1.9% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Nov 14, Everest averaged +0.3% across the last 5 years, rising in 2 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +0.9% | 3 of 5 |
| Next 10 trading days | +0.7% | 3 of 5 |
| Next 15 trading days | +0.4% | 2 of 5 |
| Next 20 trading days | +0.3% | 2 of 5 |
| Next 30 trading days | −0.1% | 3 of 5 |
For scale, EG’s typical 20-trading-day move in either direction is about 3.8%.
Everest’s market cap is $15.82B, with a P/E ratio of 8.9 and revenue of $16.20B over the last twelve months.
Coverage of Everest this week reads negative: 0 positive, 2 neutral and 10 negative headlines.
Everest’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| BRK.ABerkshire Hathaway | Distribution | 10.8% above |
| BRK.BBerkshire Hathaway | Distribution | 9.8% above |
| CBChubb | Neutral | 4.8% above |
| TRVTravelers Companies | Neutral | 6.3% above |
| HIGHartford Insurance | Neutral | 0.1% below |
| MKLMarkel | Neutral | 4.8% above |
A peer links to its own page where one exists.
Everest’s market cap is $15.82B at the Nov 13, 2026 close of $427.19, with 37.04M shares outstanding. The shares trade on a P/E ratio of 8.9.
The consensus analyst 12-month price target for Everest is $433.38, +1.4% from the last close. Of the 11 firms that rated the stock in the last 90 days, 4 rate it a buy, 7 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Everest is overvalued: the Nov 13, 2026 close of $427.19 is 5.4% above Gekko Fair Value of $405.41. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Everest is expected to report on Feb 3, 2027 (80 days away). Analysts expect earnings of $13.83 per share on revenue of $3.64B. Everest beat the earnings estimate in 4 of its last 8 reports, moving 4.6% on average across the report.
Everest’s 52-week high is $431.19 and its 52-week low is $304.55; it closed at $427.19 on Nov 13, 2026, +31.4% over the past year.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 5 items with data read as supportive (trend and earnings risk), 2 as mixed (gekkoindex and seasonality) and 1 as a headwind (fair value). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,475 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.